Novartis Ag (NVS) Current Assets (2009 - 2026)

Novartis Ag has disclosed Current Assets across 18 years of filings, most recently posting $27.4 billion for Q2 2026.

• In Q2 2026, Current Assets rose 5.44% year-over-year to $27.4 billion; the TTM figure through Jun 2026 stood at $27.4 billion (up 5.44% YoY), while the FY2025 annual figure was $30.5 billion, up 2.55% from the prior year.
• Current Assets came in at $27.4 billion for Q2 2026 at Novartis Ag, up from $26.6 billion in the prior quarter.
• In the past five years, Current Assets ranged from a high of $45.7 billion in Q3 2023 to a low of $25.1 billion in Q1 2025.
• Average Current Assets over 5 years is $31.5 billion, with a median of $30.5 billion recorded in 2023.
• Year-over-year, Current Assets surged 67.74% in 2022 and slumped 31.53% in 2024.
• Over 5 years, Current Assets stood at $36.9 billion in 2022, then declined by 17.42% to $30.5 billion in 2023, then fell by 2.55% to $29.7 billion in 2024, then gained by 2.55% to $30.5 billion in 2025, then retreated by 10.21% to $27.4 billion in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $27.4 billion in Q2 2026, $26.6 billion in Q1 2026, and $30.5 billion in Q4 2025.